Search In this Thesis
   Search In this Thesis  
العنوان
Reappraisal Of Keratinocyte’s Role In Vitiligo /
المؤلف
Shehata, Wafaa Ahmed.
هيئة الاعداد
باحث / وفاء أحمد شحاته
مشرف / ماجدة مصطفى حجاج
مناقش / منى عبد الحليم قنديل
مناقش / علا أحمد بكري
الموضوع
Keratinocytes - Laboratory manuals. Keratinocytes - cytology.
تاريخ النشر
2016.
عدد الصفحات
244 p. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الأمراض الجلدية
تاريخ الإجازة
13/11/2016
مكان الإجازة
جامعة المنوفية - كلية الطب - الأمراض الجلدية والتناسلية
الفهرس
Only 14 pages are availabe for public view

from 244

from 244

Abstract

Skin pigmentation has both individual and societal implications. Focal or
widespread loss of normal pigmentation not only renders individuals
extraordinarily vulnerable to the harmful effects of sunlight (e.g. increased risk of
skin cancer in albinism), but it can also result in severe emotional stress (e.g.
vitiligo).
Vitiligo is an acquired skin disorder caused by the disappearance of pigment
cells from the epidermis that gives rise to well defined white patches which are
often symmetrically distributed. The lack of melanin pigment makes the lesional
skin more sensitive to sunburn.
Loss of the functionality of melanocytes is responsible for vitiligo but the
real cause of vitiligo is unknown. However, some conditions including
autoimmune, genetic, neural, viral infections and oxidative stress could have an
important role in pathogenesis of vitiligo, most of them acting in concert.
Most studies on vitiligo have concentrated on the abnormality of
melanocytes rather than the abnormality of keratinocytes, although epidermal
melanocytes form a functional and structural unit with neighboring keratinocytes.
In fact, direct cell-to cell contact stimulates proliferation of melanocytes, and
growth factors produced by adjacent keratinocytes regulate the proliferation and
differentiation of melanocytes. Therefore, damage to keratinocytes might have a
significant effect on melanocyte survival.
The fine structural changes of keratinocytes degeneration seems to be
consistent with either early signs of cellular necrosis or apoptosis. Additionally,
anti-keratinocyte antibodies, which have been detected in the sera of patients with
vitiligo, resulting from keratinocyte death during the disease process.
This will result in passive melanocyte death from reduced synthesis of
keratinocyte -derived factors needed for melanocyte survival.
Aquaporin 3 has been identified in multiple epithelial tissues as a
transmembrane protein. AQP3 is detected in the epidermal keratinocytes below the
stratum corneum and is involved in skin hydration.
E-Cadherin plays a pivotal role in keratinocyte differentiation and cell-to
cell adhesion. It was reported that phosphorylated phosphatidylinositol 3-kinase
(PI3K) decreased in the depigmented epidermis of patients with vitiligo compared
to that in normally pigmented epidermis.
In fact, increased apoptosis of vitiliginous keratinocytes was found to be
caused by impaired PI3K/AKT activation, which resulted in reduced activation of
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), in the
presence of increased tumour necrosis factor alpha (TNF-α) levels. Activation of
PI3K depends on both E-Cadherin-dependent cell adhesion and tyrosine
phosphorylation events.
Therefore, a connection between AQP3 and PI3K through the E-Cadherincatenin
complex was considered. Particularly, the role of AQP3 and PI3K in
keratinocyte apoptosis.
So, co-localization of AQP3 and E-Cadherin showed that there is a
functional link between AQP3 and E-Cadherin in vitiliginous skin and they
decreased at the cell-to-cell contacts in the depigmented epidermis.
The present study aims at studying the possible role of keratinocytes in
vitiligo by the immunolocalization of E-Cadherin and AQP3 in vitiliginous skin
and hair follicles.
This case-control study was carried out on 65 subjects. These included 40
patients of different clinical varieties of vitiligo and 25 age and sex matched
normal subjects as a control group.
The diagnosis of vitiligo was made on the basis of the patient’s history and
the typical clinical features of discrete, well circumscribed, depigmented macules
and patches.
Every patient was subjected to:
A) Personal history including: Name, age and sex.
B) Present history including: Course, duration of the disease and duration of
lesion from which the biopsy was taken.
C) Family history of vitiligo.
All the studied cases were either newly diagnosed or old patients with completely
depigmented lesions.
2-Examination
A) Full general examination to exclude associated systemic diseases such as
thyroid disease, diabetes mellitus, and other autoimmune diseases.
B) Detailed dermatological examination to identify Type and distribution of
vitiligo. Assessment of disease activity was done according to VIDA score
Every case and control was subjected to
1-Skin biopsies
Three millimeter punch biopsies were taken under 2% lignocaine local
anesthesia from vitiliginous skin of patients including perilesional skin. Biopsies
were fixed in neutral formalin 10%, and submitted to routine tissue processing
ending with paraffin embedded blocks formation.
Haematoxylin and eosin stained sections were examined microscopically to
evaluate and verify epidermal and dermal pathological changes if present.
Immunohistochemical staining for E-Cadherin was done and interpretation
was evaluated as a brown cytoplasmic, membranous or membrano-cytoplasmic
stain was considered positive in in the studied cases (Lesional & perilesional skin)
and control specimens.
Immunohistochemical staining for aquaporin3 was done and interpretation
was evaluated as a brown cytoplasmic, membranous or membrano-cytoplasmic
stain in the cells was considered positive in the studied cases (Lesional &
perilesional skin) and control specimens.
The data were collected, tabulated, and analyzed by SPSS (statistical
package for social science) version 17.0 on IBM compatible computer.
Differences were considered as follows:
􀂙 Statistically significant (S) when (P<0.05).
􀂙 Highly significant (HS) when (P< 0.001).
􀂙 Not significant (NS) when (P> 0.05).
In the present work, keratinocyte expression of both E- Cadherin and AQP3
is downregulated in lesional skin comapred with perilesional and control skin both
in hair follicles and interfollicular epidermis.
The downregulation of AQP3, in cultured normal human KCs, resulted in
significantly decreased phosphorylation of PI3K-p85a and the expression of the ECadherin–
catenins. Moreover, AQP3 knockdown also reduced binding of ECadherin
and β-catenin to the same quantities of PI3K-p85a.
AQP3 downregulation will adversely affect its downstream signalling
molecules such as PI3K, E-Cadherin, and catenins which are involved in the
regulation of cell survival. This may suggest AQP3 role in vitiligo, as reduce
survival of KCs might lead to passive melanocyte death by loss of cell-cell contact
and by reduction of KC-derived growth factors.
Keratinocytes undergo apoptosis in the depigmented epidermis compared
with the normally pigmented epidermis in patients with vitiligo. This may
underscore the earlier observation detected in the present work which is KCs
vacoulization in vitiliginous epidermis.
In addition, loss of adhesion between KCs and melanocytes in vitiligo leads
to detachment of melanocytes from basal to suprabasal layer of epidermis where
they seem to be more susceptible to apoptosis.
The present study shows AQP3 and E-Cadherin downregulation in
perilesional skin compared with normal skin.
Many studies demonstrated absence and discontinuous distributions of ECadherin
in perilesional normal-appearing skin leading to altered cell–cell
adhesion. Authors added that this downregulation was associated with oxidative
stress in affected cells.
These data are in agreement with the melanocytorrhagy hypothesis that has
been proposed as the primary event in melanocytic detachment following a
mechanical trauma and with the reduced number of melanocytes in the basal layer
of reconstructed skin using melanocytes from subjects without vitilig
Therefore, from this downregulation in perilesional skin, we can postulate
that therapeutic options for vitiligo has to be
extended to pigmented skin which may help to prevent early events in “silent”
vitiligo melanocytes and prevent the spread of the disease.
In summary, both AQP3 and E-Cadherin are downregulated in vitiliginous
skin. This leads to altered cell-cell adhesion with decreased KCs survival. Loss of keratinocytes and loss of keratinocyte-melanocyte adherence leads to melanocyte
loss due to decreased keratinocyte – derived growth factors. These changes begins
in perilesional skin even before the appearance of clinically evident vitiliginous
lesions.